funding

Irish firm Neuromod raises €30m in plan to target anti-tinnitus device at US veterans

Company is aiming to commercialise its product, which treats ringing in the ears by delivering mild electrical pulses to the tongue coupled with auditory stimulation

Ross O’Neill: the chief executive of Neuromod said the company was aiming to address a paucity of innovation in tinnitus treatment